9 pharmaceutical blue chip stocks are: 600332 Baiyunshan, 600998 Jiuzhou Tong, 601607 Shanghai Pharmaceuticals, 300003 Lepu Medical, 002252 Shanghai Lai Shi, 600196 Fosun Pharmaceuticals, 600867 Tonghua Dongbao, 000963 Huadong Pharmaceuticals, 002001 Xinhecheng.
A, Baiyunshan 600332:
Company highlights: one of the most valuable domestic pharmaceutical brands
Main business: research and development, manufacturing and sales of Chinese and Western patent medicines, chemical raw materials, natural medicines, biomedicine, chemical raw materials and pharmaceutical intermediates
Conceptual themes: generic drugs, the first time in the history of the world's largest pharmaceutical company. The company's main business: wholesale and retail of pharmaceuticals, medical devices, food, health care products and other products. Chain and pharmaceutical production and R & D and value-added services
Concepts: pharmaceutical e-commerce, medical device concept, health China, MSCI concept, S&P Dow Jones A shares, Internet +, Internet health care
Third, Shanghai Pharmaceuticals 601607:
Highlights: the country's largest pharmaceutical importer and distributor
Main business: pharmaceutical R & D and manufacturing, distribution and retail
Concepts: generic consistency assessment, pharmaceutical e-commerce, avian influenza, MSCI concept, the S&P Dow Jones A shares, large consumer, Internet health care, biomedical, biological vaccines, medical device concept
four, Lepu medical 300003
Company highlights: domestic cardiovascular device leader
Main business: medical equipment and accessories technology development, production, sales.
Concepts: medical device concept, pharmaceutical e-commerce, generic consistency evaluation, MSCI concept, Internet +, Internet medical, health China
V. Shanghai Lai Shi 002252:
Company highlights: blood products industry leader
Main business: production and sales of blood products
Main business: production and sales of blood products. Sales of blood products
Concepts: S&P Dow Jones A shares, Alzheimer's concept, financing
Six, Fosun Pharmaceuticals 600196:
Company highlights: industry-leading pharmaceutical manufacturing and R & D, medical equipment and medical diagnostic enterprises
Main business: engaged in drug manufacturing and R & D, medical services, medical diagnostics and medical devices, pharmaceutical distribution and retail, which to drug manufacturing
Concepts: artemisinin, medical device concept, MSCI concept, S&P Dow Jones A shares, large consumer, generic consistency evaluation, Internet health care
seven, Tonghua Dongbao 600867:
Company highlights: the recombinant human insulin products, to fill the domestic gap
Main business: pharmaceutical R & D and manufacturing
Concept theme: biomedicine, health China, Internet health care, the concept of MSCI, the S&P Dow Jones A shares
eight, Huadong Pharmaceutical 000963:
< p> Company highlights: China's leading R & D and production of diabetes and organ transplantation drugsMain business: chemical drugs, Chinese medicine, APIs and preparations production and sales, as well as Chinese and Western patent medicines, Chinese herbal medicines, medical equipment, health products
Concepts and themes: biopharmaceuticals, pharmaceutical e-commerce, the MSCI concept, the S&P Dow Jones A shares, hyaluronic acid, financing
九、新和成002001：
Company highlights: China's largest producer of vitamin A and vitamin E
Main business: engaged in the nutritional products, flavors and fragrances, polymer composite new materials and raw materials and pharmaceuticals production and sales
Concepts: artemisinin, the six-monthly report forecasts, the concept of new materials, the MSCI concept, the S&P Dow Jones A shares. MSCI concept, S&P Dow Jones A shares
June 1, let everyone low absorption of blue equipment (300293), yesterday's last plate once again pulled up to seal the plate, this month's up or down 69.13% is enough to prove that the strength of the leading brother.
The Dragon Boat Festival seriously summed up, seriously screened the stock. From the current market point of view, most of the tourists and institutions are also uninterested in the war, volume has shrunk, the concept of stocks continue to weaken, in addition to deeper institutional involvement in photoresist and semiconductors, the other concepts of stocks continue to retracement, science and technology stocks after a substantial adjustment in the previous period, the current rebound signs have been seen, Long review new digging to a chip concept, belongs to the big fund two! The main investment in the field of equipment and materials, is about to break through the top of the box, ushering in the main ascending wave.